Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
How would you counsel patients with Type 1 or Type 2 diabetes mellitus and heart failure on the use of SGLT-2 inhibitors when they have a history of DKA?
Related Questions
Does injectable semaglutide have a higher glucose-lowering efficiency than oral semaglutide?
How do you recommend adjusting insulin pump settings when transitioning from U-100 to U-200 Humalog insulin?
Do you recommend switching from a GLP-1 agonist to insulin in female patients with type 2 diabetes who are planning to become pregnant?
Is the accuracy of continuous glucose monitors (DEXCOM or Libre) lower in patients undergoing dialysis?
What insulin pump features and settings do you utilize in patients with diabetes and end stage renal disease on intermittent hemodialysis or home peritoneal dialysis?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
How do you manage a painful nodule that is presumably due to fat necrosis at an insulin injection site?
For patients on peritoneal dialysis with type 2 diabetes mellitus, do you have a preferred long- acting insulin and time of insulin administration?
Do you change your pre-operative insulin dosing when patients are NPO for surgery, but also just recovering from newly resolved DKA?
Would you start a GLP 1 receptor agonist for treatment of Type 2 diabetes in patients with remote family history of medullary thyroid cancer without genetic testing?
